In the last 12 months, insiders at ARDELYX, INC. ($ARDX) filed 266 transactions with the SEC: 9 open-market purchases totaling $8,724,116 and 127 sales totaling $16,176,317. Net insider sentiment: net selling.
ARDELYX, INC. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- MOTT DAVID M (Director) — 15 transactions totaling $6,832,784
- RAAB MICHAEL (President & CEO) — 70 transactions totaling $5,304,001
- GRAMMER ELIZABETH A (See Remarks) — 20 transactions totaling $4,287,603
- Felsch Robert Ora (See Remarks) — 11 transactions totaling $2,076,644
- MOTT DAVID M (Not found) — 1 transaction totaling $1,946,331
View all SEC Filings for ARDELYX, INC. (ARDX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | RAAB MICHAEL | President & CEO | M | Common Stock | 20833 | $0.99 | 1,882,350.0000 | 245,247,427 | 1.12% | 0.01% |
| March 16, 2026 | RAAB MICHAEL | President & CEO | M | Stock Option (Right to Buy) | 20833 | $0.00 | 374,168.0000 | 245,247,427 | 5.27% | 0.01% |
| March 16, 2026 | RAAB MICHAEL | President & CEO | S | Common Stock | 41666 | $5.84 | 1,841,812.0000 | 245,247,427 | 2.21% | 0.02% |
| Feb. 24, 2026 | RAAB MICHAEL | President & CEO | M | Common Stock | 20833 | $0.99 | 1,903,183.0000 | 245,247,427 | 1.11% | 0.01% |
| Feb. 24, 2026 | RAAB MICHAEL | President & CEO | S | Common Stock | 41666 | $6.26 | 1,861,517.0000 | 245,247,427 | 2.19% | 0.02% |
| Feb. 24, 2026 | RAAB MICHAEL | President & CEO | M | Stock Option (Right to Buy) | 20833 | $0.00 | 395,001.0000 | 245,247,427 | 5.01% | 0.01% |
| Feb. 20, 2026 | Brady James Parker | Chief Human Resources Officer | S | Common Stock | 309 | $5.71 | 262,912.0000 | 245,247,427 | 0.12% | 0.00% |
| Feb. 20, 2026 | Reilly Joseph James | See Remarks | S | Common Stock | 602 | $5.71 | 151,792.0000 | 245,247,427 | 0.40% | 0.00% |
| Feb. 20, 2026 | Reilly Joseph James | See Remarks | S | Common Stock | 2 | $5.70 | 151,790.0000 | 245,247,427 | 0.00% | 0.00% |
| Feb. 20, 2026 | Williams Laura A | See Remarks | S | Common Stock | 7192 | $5.87 | 437,066.0000 | 245,247,427 | 1.62% | 0.00% |
| Feb. 20, 2026 | Williams Laura A | See Remarks | S | Common Stock | 984 | $5.71 | 436,082.0000 | 245,247,427 | 0.23% | 0.00% |
| Feb. 20, 2026 | Hohenleitner Susan | Chief Financial Officer | S | Common Stock | 1786 | $5.87 | 230,780.0000 | 245,247,427 | 0.77% | 0.00% |
| Feb. 20, 2026 | Hohenleitner Susan | Chief Financial Officer | S | Common Stock | 247 | $5.71 | 230,533.0000 | 245,247,427 | 0.11% | 0.00% |
| Feb. 20, 2026 | Foster Eric Duane | Chief Commercial Officer | S | Common Stock | 1 | $5.70 | 425,970.0000 | 245,247,427 | 0.00% | 0.00% |
| Feb. 20, 2026 | Foster Eric Duane | Chief Commercial Officer | S | Common Stock | 1 | $5.71 | 425,971.0000 | 245,247,427 | 0.00% | 0.00% |
| Feb. 20, 2026 | Foster Eric Duane | Chief Commercial Officer | S | Common Stock | 1261 | $5.71 | 425,972.0000 | 245,247,427 | 0.30% | 0.00% |
| Feb. 20, 2026 | Foster Eric Duane | Chief Commercial Officer | S | Common Stock | 9176 | $5.87 | 427,233.0000 | 245,247,427 | 2.10% | 0.00% |
| Feb. 20, 2026 | RAAB MICHAEL | President & CEO | S | Common Stock | 2 | $5.70 | 1,882,350.0000 | 245,247,427 | 0.00% | 0.00% |
| Feb. 20, 2026 | RAAB MICHAEL | President & CEO | S | Common Stock | 1 | $5.70 | 1,882,352.0000 | 245,247,427 | 0.00% | 0.00% |
| Feb. 20, 2026 | RAAB MICHAEL | President & CEO | S | Common Stock | 2 | $5.70 | 1,882,353.0000 | 245,247,427 | 0.00% | 0.00% |
| Feb. 20, 2026 | RAAB MICHAEL | President & CEO | S | Common Stock | 5576 | $5.71 | 1,882,355.0000 | 245,247,427 | 0.30% | 0.00% |
| Feb. 20, 2026 | RAAB MICHAEL | President & CEO | S | Common Stock | 40401 | $5.87 | 1,887,931.0000 | 245,247,427 | 2.10% | 0.02% |
| Feb. 20, 2026 | Kelliher Mike | See Remarks | S | Common Stock | 2 | $5.71 | 364,666.0000 | 245,247,427 | 0.00% | 0.00% |
| Feb. 20, 2026 | Kelliher Mike | See Remarks | S | Common Stock | 1159 | $5.71 | 364,668.0000 | 245,247,427 | 0.32% | 0.00% |
| Feb. 20, 2026 | Kelliher Mike | See Remarks | S | Common Stock | 8434 | $5.87 | 365,827.0000 | 245,247,427 | 2.25% | 0.00% |
| Feb. 20, 2026 | Brady James Parker | Chief Human Resources Officer | S | Common Stock | 2234 | $5.87 | 263,221.0000 | 245,247,427 | 0.84% | 0.00% |
| Feb. 20, 2026 | MOTT DAVID M | Not found | P | Common Stock | 333333 | $5.84 | 3,302,918.0000 | 245,247,427 | 11.22% | 0.14% |
| Feb. 20, 2026 | Bishop John E | See Remarks | S | Common Stock | 2792 | $5.87 | 339,538.0000 | 245,247,427 | 0.82% | 0.00% |
| Feb. 20, 2026 | Bishop John E | See Remarks | S | Common Stock | 386 | $5.71 | 339,152.0000 | 245,247,427 | 0.11% | 0.00% |
| Feb. 20, 2026 | Bishop John E | See Remarks | S | Common Stock | 1 | $5.70 | 339,151.0000 | 245,247,427 | 0.00% | 0.00% |
| Feb. 20, 2026 | Reilly Joseph James | See Remarks | S | Common Stock | 4387 | $5.87 | 152,394.0000 | 245,247,427 | 2.80% | 0.00% |
| Jan. 23, 2026 | Reilly Joseph James | See Remarks | A | Common Stock | 46200 | $0.00 | 156,781.0000 | 242,974,306 | 41.78% | 0.02% |
| Jan. 23, 2026 | Reilly Joseph James | See Remarks | A | Stock Option (Right to Buy) | 69360 | $0.00 | 69,360.0000 | 242,974,306 | 9999.99% | 0.03% |
| Jan. 23, 2026 | Foster Eric Duane | Chief Commercial Officer | A | Common Stock | 137945 | $0.00 | 436,409.0000 | 242,974,306 | 46.22% | 0.06% |
| Jan. 23, 2026 | Foster Eric Duane | Chief Commercial Officer | A | Stock Option (Right to Buy) | 206915 | $0.00 | 206,915.0000 | 242,974,306 | 9999.99% | 0.09% |
| Jan. 23, 2026 | RAAB MICHAEL | President & CEO | A | Common Stock | 446220 | $0.00 | 1,928,332.0000 | 242,974,306 | 30.11% | 0.18% |
| Jan. 23, 2026 | RAAB MICHAEL | President & CEO | A | Stock Option (Right to Buy) | 669330 | $0.00 | 669,330.0000 | 242,974,306 | 9999.99% | 0.28% |
| Jan. 23, 2026 | Brady James Parker | Chief Human Resources Officer | A | Common Stock | 99455 | $0.00 | 265,455.0000 | 242,974,306 | 59.91% | 0.04% |
| Jan. 23, 2026 | Brady James Parker | Chief Human Resources Officer | A | Stock Option (Right to Buy) | 149185 | $0.00 | 149,185.0000 | 242,974,306 | 9999.99% | 0.06% |
| Jan. 23, 2026 | Williams Laura A | Chief Patient Officer | A | Common Stock | 82695 | $0.00 | 444,258.0000 | 242,974,306 | 22.87% | 0.03% |
| Jan. 23, 2026 | Williams Laura A | Chief Patient Officer | A | Stock Option (Right to Buy) | 124040 | $0.00 | 124,040.0000 | 242,974,306 | 9999.99% | 0.05% |
| Jan. 23, 2026 | Bishop John E | See Remarks | A | Common Stock | 124330 | $0.00 | 342,330.0000 | 242,974,306 | 57.03% | 0.05% |
| Jan. 23, 2026 | Bishop John E | See Remarks | A | Stock Option (Right to Buy) | 186500 | $0.00 | 186,500.0000 | 242,974,306 | 9999.99% | 0.08% |
| Jan. 23, 2026 | Kelliher Mike | See Remarks | A | Stock Option (Right to Buy) | 154625 | $0.00 | 154,625.0000 | 242,974,306 | 9999.99% | 0.06% |
| Jan. 23, 2026 | Kelliher Mike | See Remarks | A | Common Stock | 103080 | $0.00 | 374,261.0000 | 242,974,306 | 38.01% | 0.04% |
| Jan. 23, 2026 | Hohenleitner Susan | Chief Financial Officer | A | Common Stock | 85670 | $0.00 | 232,566.0000 | 242,974,306 | 58.32% | 0.04% |
| Jan. 23, 2026 | Hohenleitner Susan | Chief Financial Officer | A | Stock Option (Right to Buy) | 128505 | $0.00 | 128,505.0000 | 242,974,306 | 9999.99% | 0.05% |
| Jan. 8, 2026 | Williams Laura A | Chief Patient Officer | M | Common Stock | 50000 | $0.99 | 409,896.0000 | 242,974,306 | 13.89% | 0.02% |
| Jan. 8, 2026 | Williams Laura A | Chief Patient Officer | M | Stock Option (Right to Buy) | 0 | $0.00 | 62,000.0000 | 242,974,306 | 0.00% | 0.00% |
| Jan. 8, 2026 | Williams Laura A | Chief Patient Officer | S | Common Stock | 50000 | $6.98 | 361,563.0000 | 242,974,306 | 12.15% | 0.02% |
| Nov. 21, 2025 | Reilly Joseph James | See Remarks | S | Common Stock | 11086 | $5.54 | 108,914.0000 | 242,974,306 | 9.24% | 0.00% |
| Nov. 21, 2025 | Foster Eric Duane | Chief Commercial Officer | S | Common Stock | 5814 | $5.54 | 295,684.0000 | 242,974,306 | 1.93% | 0.00% |
| Nov. 21, 2025 | Williams Laura A | Chief Patient Officer | S | Common Stock | 6426 | $5.54 | 359,896.0000 | 242,974,306 | 1.75% | 0.00% |
| Nov. 21, 2025 | Kelliher Mike | See Remarks | S | Common Stock | 5560 | $5.54 | 271,181.0000 | 242,974,306 | 2.01% | 0.00% |
| Nov. 21, 2025 | RAAB MICHAEL | President & CEO | S | Common Stock | 46887 | $5.54 | 1,480,727.0000 | 242,974,306 | 3.07% | 0.02% |
| Nov. 21, 2025 | GRAMMER ELIZABETH A | See Remarks | S | Common Stock | 5995 | $5.54 | 299,895.0000 | 242,974,306 | 1.96% | 0.00% |
| Aug. 26, 2025 | Williams Laura A | Chief Patient Officer | S | Common Stock | 30000 | $6.12 | 366,322.0000 | 238,356,222 | 7.57% | 0.01% |
| Aug. 26, 2025 | Williams Laura A | Chief Patient Officer | S | Common Stock | 50000 | $6.12 | 396,322.0000 | 238,356,222 | 11.20% | 0.02% |
| Aug. 26, 2025 | Williams Laura A | Chief Patient Officer | M | Common Stock | 50000 | $0.99 | 446,322.0000 | 238,356,222 | 12.62% | 0.02% |
| Aug. 21, 2025 | Kelliher Mike | Chief Business Officer | S | Common Stock | 5417 | $5.93 | 276,741.0000 | 238,356,222 | 1.92% | 0.00% |
| Aug. 26, 2025 | Williams Laura A | Chief Patient Officer | M | Stock Option (Right to Buy) | 50000 | $0.00 | 112,000.0000 | 238,356,222 | 30.86% | 0.02% |
| Aug. 21, 2025 | Renz Justin A | Chief Financial Officer | S | Common Stock | 7037 | $5.93 | 409,052.0000 | 238,356,222 | 1.69% | 0.00% |
| Aug. 21, 2025 | Williams Laura A | Chief Patient Officer | S | Common Stock | 6261 | $5.93 | 396,322.0000 | 238,356,222 | 1.56% | 0.00% |
| Aug. 21, 2025 | Foster Eric Duane | Chief Commercial Officer | S | Common Stock | 15308 | $5.93 | 301,498.0000 | 238,356,222 | 4.83% | 0.01% |
| Aug. 21, 2025 | GRAMMER ELIZABETH A | See Remarks | S | Common Stock | 5841 | $5.93 | 305,890.0000 | 238,356,222 | 1.87% | 0.00% |
| Aug. 21, 2025 | RAAB MICHAEL | President & CEO | S | Common Stock | 45687 | $5.93 | 1,527,614.0000 | 238,356,222 | 2.90% | 0.02% |
| June 18, 2025 | Bertrand William C JR | Director | A | Common Stock | 41551 | $0.00 | 290,707.0000 | 238,356,222 | 16.68% | 0.02% |
| June 18, 2025 | Bhanji Muna | Director | A | Stock Option (Right to Buy) | 54059 | $0.00 | 54,059.0000 | 238,356,222 | 9999.99% | 0.02% |
| June 18, 2025 | Bhanji Muna | Director | A | Common Stock | 41551 | $0.00 | 137,353.0000 | 238,356,222 | 43.37% | 0.02% |
| June 18, 2025 | Cadoret-Manier Onaiza | Director | A | Stock Option (Right to Buy) | 54059 | $0.00 | 54,059.0000 | 238,356,222 | 9999.99% | 0.02% |
| June 18, 2025 | Cadoret-Manier Onaiza | Director | A | Common Stock | 41551 | $0.00 | 151,701.0000 | 238,356,222 | 37.72% | 0.02% |
| June 18, 2025 | MOTT DAVID M | Director | A | Stock Option (Right to Buy) | 54059 | $0.00 | 54,059.0000 | 238,356,222 | 9999.99% | 0.02% |
| June 18, 2025 | MOTT DAVID M | Director | A | Common Stock | 41551 | $0.00 | 2,969,585.0000 | 238,356,222 | 1.42% | 0.02% |
| June 18, 2025 | MOTT DAVID M | Director | A | Common Stock | 31163 | $0.00 | 2,928,034.0000 | 238,356,222 | 1.08% | 0.01% |
| June 18, 2025 | Parsey Merdad | Director | A | Common Stock | 15235 | $0.00 | 57,291.0000 | 238,356,222 | 36.23% | 0.01% |
| June 18, 2025 | Rodgers Richard J | Director | A | Stock Option (Right to Buy) | 54059 | $0.00 | 54,059.0000 | 238,356,222 | 9999.99% | 0.02% |
| June 18, 2025 | Rodgers Richard J | Director | A | Common Stock | 41551 | $0.00 | 413,543.0000 | 238,356,222 | 11.17% | 0.02% |
| June 18, 2025 | Rodgers Richard J | Director | A | Common Stock | 21468 | $0.00 | 371,992.0000 | 238,356,222 | 6.12% | 0.01% |
| June 18, 2025 | Bertrand William C JR | Director | A | Stock Option (Right to Buy) | 54059 | $0.00 | 54,059.0000 | 238,356,222 | 9999.99% | 0.02% |
| June 18, 2025 | Bertrand William C JR | Director | A | Common Stock | 19390 | $0.00 | 249,156.0000 | 238,356,222 | 8.44% | 0.01% |
| June 18, 2025 | Bazemore Robert B | Director | A | Stock Option (Right to Buy) | 54059 | $0.00 | 54,059.0000 | 238,356,222 | 9999.99% | 0.02% |
| June 18, 2025 | Bazemore Robert B | Director | A | Common Stock | 41551 | $0.00 | 41,551.0000 | 238,356,222 | 9999.99% | 0.02% |
| June 16, 2025 | MOTT DAVID M | Director | P | Common Stock | 200000 | $3.63 | 2,896,871.0000 | 238,356,222 | 7.42% | 0.08% |
| June 9, 2025 | MOTT DAVID M | Director | P | Common Stock | 200000 | $3.69 | 2,696,871.0000 | 238,356,222 | 8.01% | 0.08% |
| May 20, 2025 | Foster Eric Duane | Chief Commercial Officer | S | Common Stock | 2507 | $4.08 | 316,806.0000 | 238,356,222 | 0.79% | 0.00% |
| May 20, 2025 | GRAMMER ELIZABETH A | See Remarks | S | Common Stock | 5992 | $4.08 | 311,731.0000 | 238,356,222 | 1.89% | 0.00% |
| May 20, 2025 | Kelliher Mike | See Remarks | S | Common Stock | 14522 | $4.08 | 282,158.0000 | 238,356,222 | 4.89% | 0.01% |
| May 20, 2025 | RAAB MICHAEL | President & CEO | S | Common Stock | 46817 | $4.08 | 1,573,301.0000 | 238,356,222 | 2.89% | 0.02% |
| May 20, 2025 | Renz Justin A | Chief Financial Officer | S | Common Stock | 7218 | $4.08 | 416,089.0000 | 238,356,222 | 1.71% | 0.00% |
| May 20, 2025 | Williams Laura A | Chief Medical Officer | S | Common Stock | 6421 | $4.08 | 402,583.0000 | 238,356,222 | 1.57% | 0.00% |
| May 15, 2025 | MOTT DAVID M | Director | P | Common Stock | 100000 | $3.29 | 2,496,871.0000 | 238,356,222 | 4.17% | 0.04% |
| April 28, 2025 | Parsey Merdad | Director | A | Stock Option (Right to Buy) | 64457 | $0.00 | 64,457.0000 | 238,356,222 | 9999.99% | 0.03% |
| April 28, 2025 | Parsey Merdad | Director | A | Common Stock | 42056 | $0.00 | 42,056.0000 | 238,356,222 | 9999.99% | 0.02% |
| May 2, 2025 | RAAB MICHAEL | President & CEO | M | Stock Option (Right to Buy) | 20833 | $0.00 | 415,834.0000 | 238,356,222 | 4.77% | 0.01% |
| May 2, 2025 | MOTT DAVID M | Director | P | Common Stock | 381377 | $4.22 | 2,396,871.0000 | 238,356,222 | 18.92% | 0.16% |
| May 2, 2025 | RAAB MICHAEL | President & CEO | M | Common Stock | 20833 | $0.99 | 1,661,784.0000 | 238,356,222 | 1.27% | 0.01% |
| May 2, 2025 | RAAB MICHAEL | President & CEO | S | Common Stock | 41666 | $4.25 | 1,620,118.0000 | 238,356,222 | 2.51% | 0.02% |
| April 4, 2025 | RAAB MICHAEL | President & CEO | M | Common Stock | 20833 | $0.99 | 1,682,617.0000 | 238,356,222 | 1.25% | 0.01% |
| April 4, 2025 | RAAB MICHAEL | President & CEO | M | Stock Option (Right to Buy) | 20833 | $0.00 | 436,667.0000 | 238,356,222 | 4.55% | 0.01% |
| April 4, 2025 | RAAB MICHAEL | President & CEO | S | Common Stock | 41666 | $4.59 | 1,640,951.0000 | 238,356,222 | 2.48% | 0.02% |
| March 7, 2025 | RAAB MICHAEL | President & CEO | M | Stock Option (Right to Buy) | 20834 | $0.00 | 457,500.0000 | 238,356,222 | 4.36% | 0.01% |
| March 7, 2025 | RAAB MICHAEL | President & CEO | S | Common Stock | 41668 | $5.36 | 1,660,502.0000 | 238,356,222 | 2.45% | 0.02% |
| March 7, 2025 | RAAB MICHAEL | President & CEO | M | Common Stock | 20834 | $0.99 | 1,702,170.0000 | 238,356,222 | 1.24% | 0.01% |
| Feb. 25, 2025 | Kelliher Mike | See Remarks | A | Stock Option (Right to Buy) | 205019 | $0.00 | 205,019.0000 | 238,356,222 | 9999.99% | 0.09% |
| Feb. 25, 2025 | Kelliher Mike | See Remarks | A | Common Stock | 136680 | $0.00 | 296,680.0000 | 238,356,222 | 85.43% | 0.06% |
| Feb. 25, 2025 | RAAB MICHAEL | President & CEO | A | Stock Option (Right to Buy) | 855326 | $0.00 | 855,326.0000 | 238,356,222 | 9999.99% | 0.36% |
| Feb. 25, 2025 | RAAB MICHAEL | President & CEO | A | Common Stock | 570217 | $0.00 | 1,681,336.0000 | 238,356,222 | 51.32% | 0.24% |
| Feb. 25, 2025 | Renz Justin A | Chief Financial Officer | A | Stock Option (Right to Buy) | 205019 | $0.00 | 205,019.0000 | 238,356,222 | 9999.99% | 0.09% |
| Feb. 25, 2025 | Renz Justin A | Chief Financial Officer | A | Common Stock | 136680 | $0.00 | 422,648.0000 | 238,356,222 | 47.80% | 0.06% |
| Feb. 25, 2025 | Williams Laura A | Chief Medical Officer | A | Stock Option (Right to Buy) | 157700 | $0.00 | 157,700.0000 | 238,356,222 | 9999.99% | 0.07% |
| Feb. 25, 2025 | Williams Laura A | Chief Medical Officer | A | Common Stock | 105200 | $0.00 | 409,004.0000 | 238,356,222 | 34.63% | 0.04% |
| Feb. 25, 2025 | Foster Eric Duane | Chief Commercial Officer | A | Stock Option (Right to Buy) | 205019 | $0.00 | 205,019.0000 | 238,356,222 | 9999.99% | 0.09% |
| Feb. 25, 2025 | GRAMMER ELIZABETH A | See Remarks | A | Stock Option (Right to Buy) | 205019 | $0.00 | 205,019.0000 | 238,356,222 | 9999.99% | 0.09% |
| Feb. 25, 2025 | GRAMMER ELIZABETH A | See Remarks | A | Common Stock | 136680 | $0.00 | 317,723.0000 | 238,356,222 | 75.50% | 0.06% |
| Feb. 25, 2025 | Foster Eric Duane | Chief Commercial Officer | A | Common Stock | 136680 | $0.00 | 316,680.0000 | 238,356,222 | 75.93% | 0.06% |
| Feb. 24, 2025 | MOTT DAVID M | Director | P | Common Stock | 77729 | $5.00 | 2,015,494.0000 | 238,356,222 | 4.01% | 0.03% |
| Feb. 20, 2025 | GRAMMER ELIZABETH A | See Remarks | S | Common Stock | 4291 | $5.62 | 181,043.0000 | 238,356,222 | 2.32% | 0.00% |
| Feb. 20, 2025 | Williams Laura A | Chief Medical Officer | S | Common Stock | 4941 | $5.62 | 303,804.0000 | 238,356,222 | 1.60% | 0.00% |
| Feb. 20, 2025 | Renz Justin A | Chief Financial Officer | S | Common Stock | 5171 | $5.62 | 285,968.0000 | 238,356,222 | 1.78% | 0.00% |
| Feb. 20, 2025 | RAAB MICHAEL | President & CEO | S | Common Stock | 22964 | $5.62 | 1,111,119.0000 | 238,356,222 | 2.02% | 0.01% |
| Jan. 31, 2025 | RAAB MICHAEL | President & CEO | M | Stock Option (Right to Buy) | 20833 | $0.00 | 478,334.0000 | 0 | 4.17% | 0.00% |
| Jan. 31, 2025 | RAAB MICHAEL | President & CEO | M | Common Stock | 20833 | $0.99 | 1,175,749.0000 | 0 | 1.80% | 0.00% |
| Jan. 31, 2025 | RAAB MICHAEL | President & CEO | S | Common Stock | 41666 | $5.36 | 1,134,083.0000 | 0 | 3.54% | 0.00% |
| Jan. 21, 2025 | MOTT DAVID M | Director | P | Common Stock | 199000 | $4.99 | 1,937,765.0000 | 0 | 11.44% | 0.00% |
| Jan. 16, 2025 | Rodgers Richard J | Director | M | Stock Option (Right to Buy) | 100000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 16, 2025 | Rodgers Richard J | Director | M | Common Stock | 100000 | $0.55 | 350,524.0000 | 0 | 39.92% | 0.00% |
| Jan. 7, 2025 | RAAB MICHAEL | President & CEO | M | Stock Option (Right to Buy) | 20833 | $0.00 | 499,167.0000 | 0 | 4.01% | 0.00% |
| Jan. 7, 2025 | RAAB MICHAEL | President & CEO | S | Common Stock | 41666 | $5.31 | 1,154,916.0000 | 0 | 3.48% | 0.00% |
| Jan. 7, 2025 | RAAB MICHAEL | President & CEO | M | Common Stock | 20833 | $0.99 | 1,196,582.0000 | 0 | 1.77% | 0.00% |
| Dec. 26, 2024 | MOTT DAVID M | Director | M | Stock Option (Right to Buy) | 100000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 26, 2024 | MOTT DAVID M | Director | M | Common Stock | 100000 | $0.55 | 1,738,765.0000 | 0 | 6.10% | 0.00% |
| Dec. 19, 2024 | MOTT DAVID M | Director | P | Common Stock | 213300 | $4.67 | 1,638,765.0000 | 0 | 14.96% | 0.00% |
| Dec. 10, 2024 | RAAB MICHAEL | President & CEO | M | Common Stock | 25000 | $0.99 | 1,200,749.0000 | 0 | 2.13% | 0.00% |
| Dec. 10, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 25000 | $5.26 | 1,175,749.0000 | 0 | 2.08% | 0.00% |
| Dec. 10, 2024 | RAAB MICHAEL | President & CEO | M | Stock Option (Right to Buy) | 25000 | $0.00 | 520,000.0000 | 0 | 4.59% | 0.00% |
| Nov. 25, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 25000 | $5.38 | 1,175,749.0000 | 0 | 2.08% | 0.00% |
| Nov. 20, 2024 | Williams Laura A | Chief Medical Officer | S | Common Stock | 7366 | $4.79 | 308,745.0000 | 0 | 2.33% | 0.00% |
| Nov. 20, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 31980 | $4.79 | 1,200,749.0000 | 0 | 2.59% | 0.00% |
| Nov. 20, 2024 | Blanks Robert | See Remarks | S | Common Stock | 4941 | $4.79 | 314,421.0000 | 0 | 1.55% | 0.00% |
| Nov. 20, 2024 | Renz Justin A | Chief Financial Officer | S | Common Stock | 5260 | $4.79 | 291,139.0000 | 0 | 1.77% | 0.00% |
| Nov. 20, 2024 | Rosenbaum David P. | Chief Development Officer | S | Common Stock | 2243 | $4.79 | 525,970.0000 | 0 | 0.42% | 0.00% |
| Nov. 20, 2024 | Rosenbaum David P. | Chief Development Officer | S | Common Stock | 4941 | $4.79 | 525,970.0000 | 0 | 0.93% | 0.00% |
| Nov. 20, 2024 | GRAMMER ELIZABETH A | See Remarks | S | Common Stock | 7046 | $4.79 | 185,334.0000 | 0 | 3.66% | 0.00% |
| Nov. 13, 2024 | MOTT DAVID M | Director | P | Common Stock | 215868 | $4.62 | 1,425,465.0000 | 0 | 17.85% | 0.00% |
| Nov. 11, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 2743 | $4.90 | 1,232,729.0000 | 0 | 0.22% | 0.00% |
| Nov. 6, 2024 | Rosenbaum David P. | Chief Development Officer | S | Common Stock | 27171 | $6.10 | 533,154.0000 | 0 | 4.85% | 0.00% |
| Nov. 6, 2024 | Rosenbaum David P. | Chief Development Officer | M | Common Stock | 27171 | $2.32 | 560,325.0000 | 0 | 5.10% | 0.00% |
| Nov. 6, 2024 | Rosenbaum David P. | Chief Development Officer | M | Stock Option (Right to Buy) | 27171 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 4, 2024 | Rosenbaum David P. | Chief Development Officer | M | Common Stock | 27172 | $2.32 | 560,326.0000 | 0 | 5.10% | 0.00% |
| Nov. 4, 2024 | Rosenbaum David P. | Chief Development Officer | S | Common Stock | 27172 | $5.95 | 533,154.0000 | 0 | 4.85% | 0.00% |
| Nov. 4, 2024 | Rosenbaum David P. | Chief Development Officer | M | Stock Option (Right to Buy) | 27172 | $2.32 | 27,171.0000 | 0 | 50.00% | 0.00% |
| Oct. 28, 2024 | RAAB MICHAEL | President & CEO | M | Common Stock | 25000 | $0.99 | 1,260,472.0000 | 0 | 2.02% | 0.00% |
| Oct. 28, 2024 | RAAB MICHAEL | President & CEO | M | Stock Option (Right to Buy) | 25000 | $0.00 | 545,000.0000 | 0 | 4.39% | 0.00% |
| Oct. 28, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 25000 | $5.91 | 1,235,472.0000 | 0 | 1.98% | 0.00% |
| Oct. 11, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 7500 | $6.01 | 1,235,472.0000 | 0 | 0.60% | 0.00% |
| Sept. 27, 2024 | Rosenbaum David P. | Chief Development Officer | S | Common Stock | 49564 | $6.92 | 533,154.0000 | 0 | 8.51% | 0.00% |
| Sept. 26, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 3000 | $6.07 | 1,242,972.0000 | 0 | 0.24% | 0.00% |
| Sept. 13, 2024 | Rosenbaum David P. | Chief Development Officer | S | Common Stock | 5312 | $6.26 | 582,718.0000 | 0 | 0.90% | 0.00% |
| Sept. 11, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 35000 | $5.61 | 1,245,972.0000 | 0 | 2.73% | 0.00% |
| Sept. 11, 2024 | RAAB MICHAEL | President & CEO | M | Stock Option (Right to Buy) | 35000 | $0.00 | 570,000.0000 | 0 | 5.79% | 0.00% |
| Sept. 11, 2024 | RAAB MICHAEL | President & CEO | M | Common Stock | 35000 | $0.99 | 1,280,972.0000 | 0 | 2.81% | 0.00% |
| Aug. 27, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 7500 | $6.22 | 1,244,873.0000 | 0 | 0.60% | 0.00% |
| Aug. 20, 2024 | Rosenbaum David P. | Chief Development Officer | S | Common Stock | 4969 | $5.86 | 585,354.0000 | 0 | 0.84% | 0.00% |
| Aug. 20, 2024 | Williams Laura A | Chief Medical Officer | S | Common Stock | 7412 | $5.86 | 314,740.0000 | 0 | 2.30% | 0.00% |
| Aug. 20, 2024 | Rosenbaum David P. | Chief Development Officer | S | Common Stock | 2250 | $5.86 | 585,354.0000 | 0 | 0.38% | 0.00% |
| Aug. 20, 2024 | Blanks Robert | See Remarks | S | Common Stock | 4969 | $5.86 | 319,362.0000 | 0 | 1.53% | 0.00% |
| Aug. 20, 2024 | Felsch Robert Ora | See Remarks | S | Common Stock | 3567 | $5.86 | 91,560.0000 | 0 | 3.75% | 0.00% |
| Aug. 20, 2024 | GRAMMER ELIZABETH A | See Remarks | S | Common Stock | 7089 | $5.86 | 192,380.0000 | 0 | 3.55% | 0.00% |
| Aug. 20, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 32225 | $5.86 | 1,252,373.0000 | 0 | 2.51% | 0.00% |
| Aug. 20, 2024 | Renz Justin A | Chief Financial Officer | S | Common Stock | 5289 | $5.86 | 295,257.0000 | 0 | 1.76% | 0.00% |
| Aug. 20, 2024 | Rosenbaum David P. | Chief Development Officer | M | Stock Option (Right to Buy) | 20507 | $0.00 | 49,806.0000 | 0 | 29.17% | 0.00% |
| Aug. 20, 2024 | Rosenbaum David P. | Chief Development Officer | S | Common Stock | 20507 | $6.00 | 592,573.0000 | 0 | 3.34% | 0.00% |
| Aug. 20, 2024 | Rosenbaum David P. | Chief Development Officer | M | Common Stock | 20507 | $0.99 | 613,080.0000 | 0 | 3.46% | 0.00% |
| Aug. 16, 2024 | Rosenbaum David P. | Chief Development Officer | S | Common Stock | 20000 | $5.94 | 592,573.0000 | 0 | 3.26% | 0.00% |
| Aug. 8, 2024 | Foster Eric Duane | Chief Commercial Officer | A | Stock Option (Right to Buy) | 230000 | $0.00 | 230,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 8, 2024 | Foster Eric Duane | Chief Commercial Officer | A | Common Stock | 180000 | $0.00 | 180,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 12, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 1229 | $5.71 | 1,284,598.0000 | 0 | 0.10% | 0.00% |
| July 29, 2024 | RAAB MICHAEL | President & CEO | M | Stock Option (Right to Buy) | 30000 | $0.00 | 605,000.0000 | 0 | 4.72% | 0.00% |
| July 29, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 30000 | $5.64 | 1,285,827.0000 | 0 | 2.28% | 0.00% |
| July 29, 2024 | RAAB MICHAEL | President & CEO | M | Common Stock | 30000 | $0.99 | 1,315,827.0000 | 0 | 2.33% | 0.00% |
| July 15, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 7500 | $5.97 | 1,285,827.0000 | 0 | 0.58% | 0.00% |
| June 28, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 2310 | $6.59 | 1,293,327.0000 | 0 | 0.18% | 0.00% |
| June 21, 2024 | Blanks Robert | See Remarks | S | Common Stock | 38000 | $5.96 | 324,331.0000 | 0 | 10.49% | 0.00% |
| June 14, 2024 | Rodgers Richard J | Director | A | Common Stock | 12204 | $0.00 | 250,524.0000 | 0 | 5.12% | 0.00% |
| June 14, 2024 | Rodgers Richard J | Director | A | Stock Option (Right to Buy) | 40243 | $0.00 | 40,243.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Bhanji Muna | Director | A | Stock Option (Right to Buy) | 40243 | $0.00 | 40,243.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Bertrand William C JR | Director | A | Common Stock | 11023 | $0.00 | 229,766.0000 | 0 | 5.04% | 0.00% |
| June 14, 2024 | Bertrand William C JR | Director | A | Stock Option (Right to Buy) | 40243 | $0.00 | 40,243.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Cadoret-Manier Onaiza | Director | A | Stock Option (Right to Buy) | 40243 | $0.00 | 40,243.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Bazemore Robert B | Director | A | Stock Option (Right to Buy) | 40243 | $0.00 | 40,243.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | MOTT DAVID M | Director | A | Common Stock | 17322 | $0.00 | 1,209,597.0000 | 0 | 1.45% | 0.00% |
| June 14, 2024 | MOTT DAVID M | Director | A | Stock Option (Right to Buy) | 40243 | $0.00 | 40,243.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | RAAB MICHAEL | President & CEO | M | Common Stock | 35000 | $0.99 | 1,330,637.0000 | 0 | 2.70% | 0.00% |
| June 13, 2024 | RAAB MICHAEL | President & CEO | M | Stock Option (Right to Buy) | 35000 | $0.00 | 665,000.0000 | 0 | 5.00% | 0.00% |
| June 13, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 35000 | $6.65 | 1,295,637.0000 | 0 | 2.63% | 0.00% |
| June 5, 2024 | Williams Laura A | Chief Medical Officer | S | Common Stock | 100000 | $7.13 | 322,152.0000 | 0 | 23.69% | 0.00% |
| June 5, 2024 | Williams Laura A | Chief Medical Officer | M | Common Stock | 100000 | $2.75 | 467,152.0000 | 0 | 27.24% | 0.00% |
| June 5, 2024 | Williams Laura A | Chief Medical Officer | S | Common Stock | 45000 | $7.12 | 422,152.0000 | 0 | 9.63% | 0.00% |
| June 5, 2024 | Williams Laura A | Chief Medical Officer | M | Stock Option (Right to Buy) | 100000 | $0.00 | 251,000.0000 | 0 | 28.49% | 0.00% |
| June 3, 2024 | Rosenbaum David P. | Chief Development Officer | S | Common Stock | 17872 | $7.00 | 612,573.0000 | 0 | 2.83% | 0.00% |
| May 29, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 7500 | $6.72 | 1,295,637.0000 | 0 | 0.58% | 0.00% |
| May 21, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 31484 | $7.81 | 1,303,137.0000 | 0 | 2.36% | 0.00% |
| May 21, 2024 | Williams Laura A | Chief Medical Officer | S | Common Stock | 4794 | $7.81 | 367,152.0000 | 0 | 1.29% | 0.00% |
| May 21, 2024 | Rosenbaum David P. | Chief Development Officer | S | Common Stock | 4855 | $7.81 | 630,445.0000 | 0 | 0.76% | 0.00% |
| May 21, 2024 | Rosenbaum David P. | Chief Development Officer | S | Common Stock | 2198 | $7.81 | 630,445.0000 | 0 | 0.35% | 0.00% |
| May 21, 2024 | Rodriguez Susan | Chief Commercial Officer | S | Common Stock | 6703 | $7.81 | 449,092.0000 | 0 | 1.47% | 0.00% |
| May 21, 2024 | Renz Justin A | Chief Financial Officer | S | Common Stock | 5167 | $7.81 | 300,546.0000 | 0 | 1.69% | 0.00% |
| May 21, 2024 | GRAMMER ELIZABETH A | See Remarks | S | Common Stock | 6927 | $7.81 | 199,469.0000 | 0 | 3.36% | 0.00% |
| May 21, 2024 | Felsch Robert Ora | See Remarks | S | Common Stock | 3485 | $7.81 | 95,127.0000 | 0 | 3.53% | 0.00% |
| May 21, 2024 | Blanks Robert | See Remarks | S | Common Stock | 4855 | $7.81 | 362,331.0000 | 0 | 1.32% | 0.00% |
| May 14, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 3000 | $7.99 | 1,333,297.0000 | 0 | 0.22% | 0.00% |
| May 6, 2024 | Felsch Robert Ora | See Remarks | M | Common Stock | 79101 | $0.84 | 263,935.0000 | 0 | 42.80% | 0.00% |
| May 6, 2024 | Felsch Robert Ora | See Remarks | M | Common Stock | 40000 | $2.75 | 303,935.0000 | 0 | 15.16% | 0.00% |
| May 6, 2024 | Felsch Robert Ora | See Remarks | S | Common Stock | 152988 | $8.81 | 150,947.0000 | 0 | 50.34% | 0.00% |
| May 6, 2024 | Felsch Robert Ora | See Remarks | S | Common Stock | 55000 | $8.80 | 95,947.0000 | 0 | 36.44% | 0.00% |
| May 6, 2024 | Felsch Robert Ora | See Remarks | M | Stock Option (Right to Buy) | 79101 | $0.00 | 61,525.0000 | 0 | 56.25% | 0.00% |
| May 6, 2024 | Felsch Robert Ora | See Remarks | M | Stock Option (Right to Buy) | 40000 | $0.00 | 80,000.0000 | 0 | 33.33% | 0.00% |
| May 6, 2024 | GRAMMER ELIZABETH A | See Remarks | M | Common Stock | 110250 | $0.99 | 378,243.0000 | 0 | 41.14% | 0.00% |
| May 6, 2024 | GRAMMER ELIZABETH A | See Remarks | M | Common Stock | 109687 | $2.75 | 487,930.0000 | 0 | 29.00% | 0.00% |
| May 6, 2024 | GRAMMER ELIZABETH A | See Remarks | M | Stock Option (Right to Buy) | 110250 | $0.00 | 85,750.0000 | 0 | 56.25% | 0.00% |
| May 6, 2024 | GRAMMER ELIZABETH A | See Remarks | S | Common Stock | 64233 | $8.87 | 423,697.0000 | 0 | 13.16% | 0.00% |
| May 6, 2024 | GRAMMER ELIZABETH A | See Remarks | S | Common Stock | 219937 | $8.88 | 203,760.0000 | 0 | 51.91% | 0.00% |
| May 6, 2024 | GRAMMER ELIZABETH A | See Remarks | M | Stock Option (Right to Buy) | 109687 | $0.00 | 241,313.0000 | 0 | 31.25% | 0.00% |
| May 3, 2024 | GRAMMER ELIZABETH A | See Remarks | S | Common Stock | 45000 | $9.00 | 267,993.0000 | 0 | 14.38% | 0.00% |
| May 3, 2024 | Williams Laura A | Chief Medical Officer | M | Stock Option (Right to Buy) | 30000 | $0.00 | 162,000.0000 | 0 | 15.63% | 0.00% |
| May 3, 2024 | Williams Laura A | Chief Medical Officer | S | Common Stock | 39949 | $8.35 | 370,189.0000 | 0 | 9.74% | 0.00% |
| May 3, 2024 | Williams Laura A | Chief Medical Officer | M | Common Stock | 30000 | $0.99 | 410,138.0000 | 0 | 7.89% | 0.00% |
| April 29, 2024 | RAAB MICHAEL | President & CEO | M | Stock Option (Right to Buy) | 30000 | $0.00 | 670,000.0000 | 0 | 4.29% | 0.00% |
| April 29, 2024 | RAAB MICHAEL | President & CEO | M | Common Stock | 30000 | $0.99 | 1,366,297.0000 | 0 | 2.25% | 0.00% |
| April 29, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 30000 | $6.40 | 1,336,297.0000 | 0 | 2.20% | 0.00% |
| April 15, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 7500 | $7.06 | 1,336,297.0000 | 0 | 0.56% | 0.00% |
| April 1, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 1518 | $7.31 | 1,343,797.0000 | 0 | 0.11% | 0.00% |
| March 25, 2024 | Kelliher Mike | See Remarks | A | Stock Option (Right to Buy) | 205000 | $0.00 | 205,000.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | Kelliher Mike | See Remarks | A | Common Stock | 160000 | $0.00 | 160,000.0000 | 0 | 9999.99% | 0.00% |
| March 20, 2024 | GRAMMER ELIZABETH A | See Remarks | S | Common Stock | 86000 | $7.73 | 312,993.0000 | 0 | 21.55% | 0.00% |
| March 15, 2024 | Blanks Robert | See Remarks | G | Common Stock | 1000 | $0.00 | 367,186.0000 | 0 | 0.27% | 0.00% |
| Feb. 26, 2024 | Rosenbaum David P. | Chief Development Officer | S | Common Stock | 5183 | $9.20 | 632,513.0000 | 0 | 0.81% | 0.00% |
| Feb. 20, 2024 | Felsch Robert Ora | See Remarks | S | Common Stock | 2352 | $8.75 | 184,834.0000 | 0 | 1.26% | 0.00% |
| Feb. 20, 2024 | Rosenbaum David P. | Chief Development Officer | S | Common Stock | 5017 | $8.75 | 637,696.0000 | 0 | 0.78% | 0.00% |
| Feb. 20, 2024 | Rosenbaum David P. | Chief Development Officer | S | Common Stock | 2294 | $8.75 | 637,696.0000 | 0 | 0.36% | 0.00% |
| Feb. 20, 2024 | Renz Justin A | Chief Financial Officer | S | Common Stock | 5341 | $8.75 | 304,835.0000 | 0 | 1.72% | 0.00% |
| Feb. 20, 2024 | RAAB MICHAEL | President & CEO | S | Common Stock | 22917 | $8.75 | 1,345,315.0000 | 0 | 1.67% | 0.00% |
| Feb. 20, 2024 | Blanks Robert | See Remarks | S | Common Stock | 5017 | $8.75 | 368,186.0000 | 0 | 1.34% | 0.00% |
| Feb. 20, 2024 | GRAMMER ELIZABETH A | See Remarks | S | Common Stock | 4432 | $8.75 | 398,993.0000 | 0 | 1.10% | 0.00% |
| Feb. 20, 2024 | Rodriguez Susan | Chief Commercial Officer | S | Common Stock | 6928 | $8.75 | 452,795.0000 | 0 | 1.51% | 0.00% |
| Feb. 20, 2024 | Williams Laura A | Chief Medical Officer | S | Common Stock | 4803 | $8.75 | 380,138.0000 | 0 | 1.25% | 0.00% |
| Feb. 8, 2024 | Rosenbaum David P. | Chief Development Officer | S | Common Stock | 15344 | $9.18 | 645,007.0000 | 0 | 2.32% | 0.00% |
| Jan. 16, 2024 | Blanks Robert | See Remarks | A | Stock Option (Right to Buy) | 145000 | $0.00 | 145,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 16, 2024 | Blanks Robert | See Remarks | A | Common Stock | 112750 | $0.00 | 373,203.0000 | 0 | 43.29% | 0.00% |
| Jan. 16, 2024 | Felsch Robert Ora | See Remarks | A | Stock Option (Right to Buy) | 99000 | $0.00 | 99,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 16, 2024 | Felsch Robert Ora | See Remarks | A | Common Stock | 70120 | $0.00 | 187,186.0000 | 0 | 59.90% | 0.00% |
| Jan. 16, 2024 | GRAMMER ELIZABETH A | See Remarks | A | Stock Option (Right to Buy) | 164000 | $0.00 | 164,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 16, 2024 | GRAMMER ELIZABETH A | See Remarks | A | Common Stock | 127750 | $0.00 | 403,425.0000 | 0 | 46.34% | 0.00% |
| Jan. 16, 2024 | RAAB MICHAEL | President & CEO | A | Stock Option (Right to Buy) | 605904 | $0.00 | 605,904.0000 | 0 | 9999.99% | 0.00% |
| Jan. 16, 2024 | RAAB MICHAEL | President & CEO | A | Common Stock | 475000 | $0.00 | 1,368,232.0000 | 0 | 53.18% | 0.00% |
| Jan. 16, 2024 | Renz Justin A | Chief Financial Officer | A | Stock Option (Right to Buy) | 164000 | $0.00 | 164,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 16, 2024 | Renz Justin A | Chief Financial Officer | A | Common Stock | 127750 | $0.00 | 310,176.0000 | 0 | 70.03% | 0.00% |
| Jan. 16, 2024 | Rodriguez Susan | Chief Commercial Officer | A | Stock Option (Right to Buy) | 145000 | $0.00 | 145,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 16, 2024 | Rodriguez Susan | Chief Commercial Officer | A | Common Stock | 112750 | $0.00 | 459,723.0000 | 0 | 32.50% | 0.00% |
| Jan. 16, 2024 | Rosenbaum David P. | Chief Development Officer | A | Stock Option (Right to Buy) | 99000 | $0.00 | 244,000.0000 | 0 | 68.28% | 0.00% |
| Jan. 16, 2024 | Rosenbaum David P. | Chief Development Officer | A | Stock Option (Right to Buy) | 145000 | $0.00 | 244,000.0000 | 0 | 146.46% | 0.00% |
| Jan. 16, 2024 | Rosenbaum David P. | Chief Development Officer | A | Common Stock | 70120 | $0.00 | 660,351.0000 | 0 | 11.88% | 0.00% |
| Jan. 16, 2024 | Rosenbaum David P. | Chief Development Officer | A | Common Stock | 112750 | $0.00 | 660,351.0000 | 0 | 20.59% | 0.00% |
| Jan. 16, 2024 | Williams Laura A | Chief Medical Officer | A | Stock Option (Right to Buy) | 152127 | $0.00 | 152,127.0000 | 0 | 9999.99% | 0.00% |
| Jan. 16, 2024 | Williams Laura A | Chief Medical Officer | A | Common Stock | 118750 | $0.00 | 384,941.0000 | 0 | 44.61% | 0.00% |
| Jan. 8, 2024 | Rosenbaum David P. | Chief Development Officer | S | Common Stock | 30000 | $6.64 | 477,481.0000 | 0 | 5.91% | 0.00% |